Your browser doesn't support javascript.
loading
The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia.
Rees, Matthew J; Wu, Simon; Mokoonlall, Mridula; Dix, Caroline H K; Bryant, Christian E; D'Rozario, James; Schwarer, Anthony; Grigg, Andrew; Tiong, Ing Soo.
Afiliação
  • Rees MJ; Department of Clinical Haematology, Austin Health, Melbourne, Australia.
  • Wu S; Department of Clinical Haematology, Eastern Health, Melbourne, Australia.
  • Mokoonlall M; Department of Clinical Haematology, Canberra Hospital, Canberra, Australia.
  • Dix CHK; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Bryant CE; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia.
  • D'Rozario J; Department of Clinical Haematology, Canberra Hospital, Canberra, Australia.
  • Schwarer A; Department of Clinical Haematology, Austin Health, Melbourne, Australia.
  • Grigg A; Department of Clinical Haematology, Eastern Health, Melbourne, Australia.
  • Tiong IS; Department of Clinical Haematology, Austin Health, Melbourne, Australia.
Leuk Lymphoma ; 62(10): 2531-2534, 2021 10.
Article em En | MEDLINE | ID: mdl-33899667
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article